THMO logo

ThermoGenesis Holdings (THMO) Stock

Profile

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

05 June 1987

Indexes:

Not included

Website:

http://www.thermogenesis.com

Description:

ThermoGenesis Holdings (THMO) is a biotechnology company that develops and sells products for cell and tissue processing. Their focus is on regenerative medicine, helping to improve treatments for various medical conditions by using advanced technologies to process and store cells for therapeutic use.

Key Details

Price

$0.00

Market Cap

$3976.40(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9.45 M(-9.90% YoY)

Annual EPS

-$7.59(+62.89% YoY)

PE Ratio

-

Annual ROE

1078.28%

Annual Debt To Equity

-4.59

Beta

-3.50

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Aug 12, 2021

Recent annual earnings:

Mar 17, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 22, 2022

Analyst ratings

Recent major analysts updates

14 Nov '23 HC Wainwright & Co.
Buy
11 Aug '23 HC Wainwright & Co.
Buy
16 May '23 HC Wainwright & Co.
Buy
03 Apr '23 HC Wainwright & Co.
Buy
12 Aug '22 HC Wainwright & Co.
Buy
13 Nov '20 HC Wainwright & Co.
Buy
17 Apr '20 H.C. Wainwright
Buy

Screeners with THMO included

Small cap stocks
NASDAQ earnings calendar
Stocks cheaper than 1 dollar
Stocks below SMA 200
Stocks with low beta

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.00
THMO price is $0.00

Price YTD Change

-99.92%
THMO price is down -99.92% since January 1st

Price All-time High

$230400.00
THMO price is currently -100.00% below its historical high of $230400.00

Market Cap

$3976.40
THMO market capitalization is $3976.40

Beta

-3.50
THMO beta is -3.50

200-day SMA

$0.39
THMO 200-day simple moving average is currently -99.87% below its 200-day simple moving average

14-day RSI

31.71
THMO 14-day relative strength index is 31.71

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

-3.07%
THMO annual revenue is down -3.07% over the past 3 years

Annual Revenue Estimate

$16.90 M
THMO annual revenue is currently -44.11% lower than the consensus analysts' forecast

Annual Net Income 3-Year Change

-9.93%
THMO annual net profit is down -9.93% over the past 3 years

Annual EPS 3-Year Change

+93.51%
THMO annual earnings per share is up +93.51% over the past 3 years

Annual Gross Profit

$1.93 M
THMO annual gross profit is $1.93 million

Annual Operating Profit

-$6.57 M
THMO annual operaing income is -$6.57 million

Annual Operating Profit 3-Year Change

+26.09%
THMO annual operaing income is up +26.09% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Gross Margin Sector Rank

15.54%
THMO annual gross profit margin is higher than 15.54% of companies in Healthcare sector

Annual Operating Margin Sector Rank

48.71%
THMO annual operating profit margin is higher than 48.71% of companies in Healthcare sector

Annual Net Margin Sector Rank

36.05%
THMO annual net profit margin is higher than 36.05% of companies in Healthcare sector

Annual ROE

1078.28%
THMO annual return on equity is 1078.28%

Annual ROA

-117.41%
THMO annual return on assets is -117.41%

Annual EBIT

-$8.89 M
THMO annual earnings before interest & taxes is -$8.89 million

Annual EBITDA

-$7.74 M
THMO annual earnings before interest, taxes, depreciation & amortization is -$7.74 million

Annual Interest Coverage Ratio

-0.89
THMO annual interest coverage ratio is -0.89

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PB Ratio Sector Rank

16.23%
THMO price to book ratio is higher than 16.23% of companies in Healthcare sector

PS Ratio Sector Rank

0.66%
THMO price to sales ratio is higher than 0.66% of companies in Healthcare sector

Enterprise Value

$5.75 M
THMO enterprise value is $5.75 million

Enterprise Value 1-Year Change

-17.38%
THMO enterprise value is down -17.38% year-on-year

EV/EBITDA

-0.83
THMO EV/EBITDA is -0.83

EV/EBITDA Sector Rank

52.13%
THMO EV/EBITDA is higher than 52.13% of companies in Healthcare sector

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Debt To Equity Sector Rank

2.08%
THMO annual debt to equity ratio is higher than 2.08% of companies in Healthcare sector

Annual Quick Ratio

0.32
THMO annual quick ratio is 0.32

Annual Quick Ratio Sector Rank

3.45%
THMO annual quick ratio is higher than 3.45% of companies in Healthcare sector

Annual Current Ratio

0.44
THMO annual current ratio is 0.44

Annual Current Ratio Sector Rank

5.55%
THMO annual current ratio is higher than 5.55% of companies in Healthcare sector

Annual Total Assets

$11.23 M
THMO annual total assets is $11.23 million

Annual Current Assets

$5.18 M
THMO annual total current assets is $5.18 million

Annual Total Liabilities

$14.82 M
THMO annual total liabilities is $14.82 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

+74.15%
THMO annual cash flow from operations is up +74.15% over the past 3 years

Annual CFI 3-Year Change

-7434.78%
THMO annual cash flow from investing activities is down -7434.78% over the past 3 years

Annual CFF 3-Year Change

-81.18%
THMO annual cash flow from financing activities is down -81.18% over the past 3 years

Annual CAPEX

$1.73 M
THMO annual capital expenditures is $1.73 million

Annual CAPEX 3-Year Change

+7434.78%
THMO annual capital expenditures is up +7434.78% over the past 3 years

Annual FCF

-$5.45 M
THMO annual free cash flow is -$5.45 million

Annual FCF 3-Year Change

+62.17%
THMO annual free cash flow is up +62.17% over the past 3 years

Institutional Ownership

Similar stocks

VIVE logo
Viveve Medical (VIVE)
ARDS logo
Aridis Pharmaceuticals (ARDS)
BTTX logo
Better Therapeutics (BTTX)
MOTS logo
Motus GI Holdings (MOTS)
AMPE logo
Ampio Pharmaceuticals (AMPE)
STAB logo
Statera Biopharma (STAB)
NMRD logo
Nemaura Medical (NMRD)
CMRA logo
Comera Life Sciences Holdings (CMRA)
EFTR logo
eFFECTOR Therapeutics (EFTR)
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
THMO
Seeking Alpha13 November 2023

ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
THMO
PRNewsWire08 August 2023

Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.

ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
THMO
Seeking Alpha15 May 2023

ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter ended March 31, 2023.

FAQ

  • What is the primary business of ThermoGenesis Holdings?
  • What is the ticker symbol for ThermoGenesis Holdings?
  • Does ThermoGenesis Holdings pay dividends?
  • What sector is ThermoGenesis Holdings in?
  • What industry is ThermoGenesis Holdings in?
  • What country is ThermoGenesis Holdings based in?
  • When did ThermoGenesis Holdings go public?
  • Is ThermoGenesis Holdings in the S&P 500?
  • Is ThermoGenesis Holdings in the NASDAQ 100?
  • Is ThermoGenesis Holdings in the Dow Jones?
  • When was ThermoGenesis Holdings's last earnings report?
  • When does ThermoGenesis Holdings report earnings?

What is the primary business of ThermoGenesis Holdings?

ThermoGenesis Holdings (THMO) is a biotechnology company that develops and sells products for cell and tissue processing. Their focus is on regenerative medicine, helping to improve treatments for various medical conditions by using advanced technologies to process and store cells for therapeutic use.

What is the ticker symbol for ThermoGenesis Holdings?

The ticker symbol for ThermoGenesis Holdings is NASDAQ:THMO

Does ThermoGenesis Holdings pay dividends?

No, ThermoGenesis Holdings does not pay dividends

What sector is ThermoGenesis Holdings in?

ThermoGenesis Holdings is in the Healthcare sector

What industry is ThermoGenesis Holdings in?

ThermoGenesis Holdings is in the Medical Devices industry

What country is ThermoGenesis Holdings based in?

ThermoGenesis Holdings is headquartered in United States

When did ThermoGenesis Holdings go public?

ThermoGenesis Holdings's initial public offering (IPO) was on 05 June 1987

Is ThermoGenesis Holdings in the S&P 500?

No, ThermoGenesis Holdings is not included in the S&P 500 index

Is ThermoGenesis Holdings in the NASDAQ 100?

No, ThermoGenesis Holdings is not included in the NASDAQ 100 index

Is ThermoGenesis Holdings in the Dow Jones?

No, ThermoGenesis Holdings is not included in the Dow Jones index

When was ThermoGenesis Holdings's last earnings report?

ThermoGenesis Holdings's most recent earnings report was on 12 August 2021

When does ThermoGenesis Holdings report earnings?

The date for ThermoGenesis Holdings's next earnings report has not been announced yet